A study on the immune response and safety of inactivated poliovirus vaccine (IPV) when co-administered with human rotavirus (HRV) porcine circovirus (PCV)-free vaccine in healthy Chinese infants

Trial Identifier: 218485
Sponsor: GlaxoSmithKline
Start Date: March 2024
Primary Completion Date: October 2024
Study Completion Date: October 2024
Condition: Digestive & Intestinal - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Mianyang, China, 610041
China Neijiang, China, 641200
China Wenshan, China, 663100
China WENSHAN, China, 663300
China Yuechi-Guang'an, China, 638300